(Image via AbbVie)

AbbVie to Present at the SVB Leerink 9th Annual Global Healthcare Conference

Originally posted on AbbVie.com

AbbVie, a research-based global biopharmaceutical company, will participate in the SVB Leerink 9th Annual Global Healthcare Conference on Tuesday, February 25.  Michael Severino, M.D., vice chairman and president and Robert A. Michael, executive vice president and chief financial officer, will present at 9:30 a.m. Central time.

A live audio webcast of the presentation will be accessible through AbbVie’s Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.

About AbbVie

AbbVie is a global, research and development-based biopharmaceutical company committed to developing innovative advanced therapies for some of the world’s most complex and critical conditions. The company’s mission is to use its expertise, dedicated people and unique approach to innovation to markedly improve treatments across four primary therapeutic areas: immunology, oncology, virology and neuroscience. In more than 75 countries, AbbVie employees are working every day to advance health solutions for people around the world. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, FacebookLinkedIn or Instagram.

 

Latest News

feinstein, northwell

Northwell Health’s Feinstein Institutes Teams Up with Sanofi, Regeneron Pharmaceuticals, Gilead Sciences to Test COVID-19 Treatments

The research arm of Northwell Health (No. 2 on DiversityInc’s 2019 Top Hospitals & Health Systems), the Feinstein Institutes for Medical Research, is partnering with Gilead Sciences, Regeneron Pharmaceuticals and Sanofi (No. 31 on DiversityInc’s 2019 Top 50 Companies for Diversity) to identify treatments for people hospitalized with moderate to severe…

Wells Fargo Announces Aid for Customers and Communities Impacted by COVID-19

Comprehensive response includes suspending residential foreclosure sales, fee waivers and acceleration of $175 million in donations to help the most vulnerable Originally published on newsroom.wf.com. Wells Fargo & Company (NYSE: WFC) today announced additional comprehensive steps to help customers, communities and employees grappling with the impact of COVID-19. The company…

Humana Foundation Donates $500,000 in Support of Coronavirus Pandemic Relief and Recovery Efforts

Originally published on Humana.com – Partnership with Feeding America will support COVID-19 response funds addressing food and financial needs in communities across the U.S. – Collaborative effort in greater Louisville area will offer free COVID-19 screenings The Humana Foundation, the philanthropic arm of Humana Inc., announced today it will provide $500,000…

Marshall, NBA, CEO

Women’s History Month Profiles: Cynthia ‘Cynt’ Marshall, First Black Woman NBA CEO

Known best for: Becoming the CEO of the Dallas Mavericks — the first African American woman CEO in the NBA During Women’s History Month, DiversityInc is honoring a series of woman innovators and history makers who are often overlooked in mainstream media coverage and history books. Check back throughout March…

Novartis Announces Broad Range of Initiatives to Respond to COVID-19 Pandemic and Creates $20 Million Global Fund to Support Impacted Communities

Originally published on novartis.com. Novartis COVID-19 Response Fund will provide grants of up to USD 1 million to support communities around the world most impacted by the Coronavirus outbreak Novartis to join collaborative R&D efforts with the Bill & Melinda Gates Foundation, Wellcome, and Mastercard -supported COVID-19 Therapeutics Accelerator and…